Switching cholinesterase inhibitor therapy in Alzheimer's disease - donepezil to rivastigmine, is it worth it?

被引：34

作者：

Bullock, R ^{[1
]}

Connolly, C ^{[1
]}

机构：

[1] Victoria Hosp, Kingshill Res Ctr, Swindon SN1 4HZ, Wilts, England

来源：

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY | 2002年 / 17卷 / 03期

关键词：

D O I：

10.1002/gps.542

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

[No abstract available]

引用

收藏

页码：288 / 289

页数：2

相关论文

共 3 条

[1] Donepezil - A review of its use in Alzheimer's disease [J].

Dooley, M ;

Lamb, HM .

DRUGS & AGING, 2000, 16 (03) :199-226

[2]

*NAT I CLIN EXC MC, 2001, GUID US DON RIV GAL

[3] Rivastigmine - A review of its use in Alzheimer's disease [J].

Spencer, CM ;

Noble, S .

DRUGS & AGING, 1998, 13 (05) :391-411